Aster Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Aster Capital Management's JAZZ Position: Q3 2026 in Review
Aster Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2026, closing a stake of 1,578 shares — an estimated $380K sold.
Aster Capital Management first reported a position in JAZZ in Q1 2025 and held it in 6 quarters. The position peaked at $1.63M in Q1 2025. 670 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Aster Capital Management reported no remaining Jazz Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Aster Capital Management sold 1,578 Jazz Pharmaceuticals shares in Q3 2026, an estimated $380K.
- Aster Capital Management first reported a position in Jazz Pharmaceuticals in Q1 2025 and held it in 6 quarters.
- Aster Capital Management's Jazz Pharmaceuticals position peaked at $1.63M in Q1 2025.
- 670 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.